Abstract
Structure-based virtual screening techniques requirereliable scoring functions to discriminate potential substrates effectively. In this study we compared the performance of GOLD, PMF, DOCK and FlexX scoring functions in FlexX flexible docking to cytochrome P450cam binding site. Crystal structures of protein-substrate complexes were most effectively reproduced by the FlexX/PMF method. On the other hand, the FlexX/GOLD approach provided the best correlation between experimental binding constants and predicted scores. Binding modes selected by the FlexX/PMF approach were rescored by GOLD to obtain a reliable measure of binding energetics. The effectiveness of the FlexX/PMF/GOLD method was demonstrated by the correct classification of 32 out of the 33 experimentally studied compounds and also in a virtual HTS test on a library of 10,000 compounds. Although almost all the available functions were developed to be general, our study on cytochrome P450cam substrates suggests that careful selection or even tailoring the scoring function might increase the prediction power of virtual screens significantly. The FlexX/PMF/GOLD methodology was tested on cytochrome P450 3A4 substrates and inhibitors. This preliminary study revealed that the combined function was able to recognise 334 out of the 345 compounds bound to 3A4.
Similar content being viewed by others
References
Lipinski, C.A., Lombardo, F., Dominy, B.W. and Feeney, P.J., Adv. Drug Deliv. Rev., 23 (1997) 3.
Walters, W.P. and Ajay, Murcko, M.A., Curr. Opin. Chem. Biol., 3 (2000) 384.
Trabit, M.H. and Berman, J., Curr. Opin. Chem. Biol., 2 (1998) 411.
Pickett, S.D., McLay, I.M. and Clark, D.E., J. Chem. Inf. Comput. Sci., 40 (2000) 263.
Ajay, Walters, W.P., Murcko and, M.A., J. Med. Chem., 41 (1998) 3314.
Sadowski, J. and Kubinyi, H., J. Med. Chem., 41 (1998) 3325.
Palm, K, Stenberg, P., Luthmann, K. and Arthursson, P., Pharm. Res., 14 (1997) 568.
Winiwarter, S., Bonham, N.M., Ax, F., Hallberg, A. Lennernas, H. and Karlen, A., J. Med. Chem., 41 (1998) 4939.
Clark, D.E., J. Pharm. Sci., 88 (1999) 807.
Crivori, P., Cruciani, G., Carrupt, P. A. and Testa, B., J. Med. Chem., 43 (2000) 2204.
Keserű, G.M., Molnár, L. and Greiner, I., Comb. Chem. & HTS, 3 (2000) 535.
Wessel, M.D., Jurs, P.C., Tolan, J.W. and Muskal, S.M., J. Chem. Inf. Comput. Sci., 38 (1998) 726.
Yoshida, F. and Topliss, J.G., J. Med. Chem., 43 (2000) 2527.
Smith, D.A. and van de Waterbeemd, H., Curr. Opin. Chem. Biol., 3 (1999) 373.
Keserű, G.M., Balogh, G.T., Czudor, I., Karancsi, T., Fehér, A. and Bertó k, B., J. Agric. Food Chem., 47 (1999) 762.
Lewis, D.F.W., Biochem. Pharmacol., 60 (2000) 293.
Metabolite, MDL Information Systems, San Leandro, CA, USA, 1997.
Pallas for Windows 3.0, Metabolic Prediction Module: MetabolExpert 10.0, CompuDrug Chemistry Ltd, USA, 1998.
de Groot, M.J., Ackland, M.J., Horne, V.A., Alex, A.A. and Jones, B.C., J. Med. Chem., 42 (1999) 4062.
Ekins, S., Bravi, G., Wikel, J.H. and Wrighton, S.A., J. Pharmacol. Exp. Ther., 291 (1999) 424.
Rao, S., Aoyama, R., Schrag, M., Trager, W.F., Rettie A. and Jones, J.P., J. Med. Chem. 43 (2000) 2789.
Harris, D. and Loew G., J. Am. Chem. Soc., 117 (1995) 2738.
Paulsen, M.D. and Ornstein, R.L., Protein Eng., 9 (1996) 567.
Keserű, G.M., Kolossváry, I. and Bertó k, B., J. Am. Chem. Soc., 119 (1997) 5127.
Ortiz de Montellano, P.R. (Ed.) Cytochrome P450 Structure, Mechanism and Biochemistry, Plenum Press, New York, NY, 1995.
Williams, P.A., Cosme, J., Sridhar, V., Johnson, E.F. and McRee, D.E., Mol. Cell, 5 (2000) 121.
Rarey, M., Kramer, B., Lengauer, T. and Klebe, G., J. Mol. Biol., 261 (1996) 470.
Sybyl version 6.6, Tripos Inc. 1699 South Hanley Road, St. Luis, MI, USA.
Böhm, H.J., J. Comput. Aid. Mol. Des., 8 (1994) 243.
Jones, G., Willett, P. and Glen, R.C., J. Mol. Biol., 245 (1995) 43.
Muegge, I. and Martin, Y.C., J. Med. Chem., 42 (1999) 791.
Meng, C., Shoichet, B.K. and Kuntz, I.D., J. Comp. Chem., 13 (1992) 505.
Bernstein, F.C., Koetzle, T.F., Williams, G.J.B., Meyer, E.T.J., Brice, M.D., Rodgers, J.R., Kennard, O., Shimanouchi, T. and Tasumi, M., J. Mol. Biol., 112 (1977) 535.
Rusinko, A., Sheridan, R.P., Nilakatan, R., Haraki, K.S., Bauman, N. and Venkatarahavan, R., J. Chem. Inf. Comput. Sci., 29 (1989) 251.
Kramer, B., Rarey, M. and Lengauer, T., Proteins: Sturct. Funct. Gen., 37 (1999) 228.
Knegtel, R.M.A., Bayada, D.M., Engh, R.A., von der Saal, W., Geerestein, V.J. and Grootenhuis, P.D.J., J. Comput. Aid. Drug Des., 13 (1999) 167.
Ha, S., Andreani, R., Robbins, A. and Muegge, I., J. Comput. Aid. Drug Des., 14 (2000) 435.
Bissantz, C., Folkers, G. and Rognan, D., J. Med. Chem., 43 (2000) 4759.
De Voss, J.J., Sibbesen, O., Zhang, Z. and Ortiz de Montellano, P.R., J. Am. Chem. Soc., 119 (1997) 5489.
Zhang, Z., Sibbesen, O., Johnson, R.A. and Ortiz de Montellano, P.R., J. Bioorg. Med. Chem., 6 (1998) 1501.
Keserű, G.M., Volk, B. and Balogh, G.T., J. Biomol. Struct. Dyn., 17 (2000) 759.
Human P450 Metabolism database created by Prof. Slobodan Rendic, Zagreb University, Croatia, available at www.gentest.com/human_p450_database/index.html
Keserű, G.M., in preparation
Walters, P.W., Stahl, M.T. and Murcko, M.A., Drug Disc. Today, 3 (1998) 160.
Charifson, P.S., Corkery, J.J., Murcko, M.A. and Walters, W.P., J. Med. Chem., 42 (1999) 5100.
Tame, J.R.H., J. Comput. Aid. Mol. Des., 13 (1999) 99.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Keserű, G.M. A virtual high throughput screen for high affinity cytochrome P450cam substrates. Implications for in silico prediction of drug metabolism. J Comput Aided Mol Des 15, 649–657 (2001). https://doi.org/10.1023/A:1011911204383
Issue Date:
DOI: https://doi.org/10.1023/A:1011911204383